Jointown Pharmaceutical Group

Jointown Pharmaceutical Group Co., Ltd. is a large enterprise group mainly dealing in western medicines, traditional Chinese medicines, and medical devices, serving medical institutions, wholesale enterprises, and retail pharmacies as its main customers, and providing customers with various value-added services such as information and logistics. Based in the pharmaceutical and health industry, the company is one of the few enterprises with a nationwide network in China's pharmaceutical commercial sector. It was listed on the Shanghai Stock Exchange on November 2, 2010 (stock abbreviation: Jointown, stock code: 600998), and is a leading listed company in China's pharmaceutical commercial industry. The company has ranked among the top of China's pharmaceutical commercial enterprises for many consecutive years, and with a brand value of 2.6 billion yuan, it ranked 130th on the "2014 Hurun Brand List." In 2015, it ranked 138th on the Fortune (Chinese edition) Top 500 and 310th on the China Top 500 Enterprises.
Jointown was founded in March 1999, with its headquarters in Wuhan, Hubei Province. As of September 30, 2015, its registered capital was 1.647 billion yuan, total assets were 30.873 billion yuan, and operating revenue reached 36.455 billion yuan, an increase of 19.02% over the same period last year. Operating profit was 375 million yuan, an increase of 26.91% over the same period last year. The company has more than 10,000 employees and 850 directly operated and franchised retail chain pharmacies. In 2014, the company achieved annual operating revenue of 41.068 billion yuan and paid taxes of 688 million yuan.
At present, Jointown deals in more than 14,000 varieties and over 160,000 product specifications, with 5,600 upstream suppliers and more than 70,000 downstream customers. It has obtained national or regional general distribution or general agency qualifications for more than 240 drugs in China, ensuring diversified customer needs and satisfying a "one-stop" procurement experience. At the same time, the company has successively built 22 provincial-level subsidiaries (large pharmaceutical logistics centers), 31 prefecture-level and municipal-level branch companies (regional distribution centers), and nearly 400 terminal distribution points in most regional central cities and provincial capitals including Hubei, Beijing, Henan, Xinjiang, Shanghai, Guangdong, Shandong, Fujian, Jiangsu, Chongqing, Jiangxi, Liaoning, Sichuan, Gansu, Inner Mongolia, Tianjin, Guangxi, Heilongjiang, Zhejiang, Anhui, Shanxi, and Jilin, establishing a logistics distribution network covering most county-level administrative regions across the country.
Hubei Jointown Supply Chain Management Co., Ltd. was established on March 31, 2014. Its main business categories include maternal and infant products, daily chemical washing and care, beauty makeup, and food. Its business channels cover OTC pharmacies, maternal and infant stores, supermarkets, department stores, hospitals, and e-commerce. As of December 2016, sales reached 2.93 billion yuan, making it a key strategic business segment cultivated by the Jointown Group. The brands it operates include Abbott, Wyeth, Nestle, Biostime, L'Oreal, Ferrero, Dettol, Friso, and many other first-tier brands, with 1,500 SKUs.